Latest News for: analgesics

Edit

Investors wooed for new analgesic

Hong Kong Standard 08 Oct 2024
Themis Qi. CK Life Sciences (0775) said it will welcome investments for the ongoing development of an analgesic after announcing one of its biotech subsidiaries will merge with a US-listed peer ... The Standard Channel. IOS Android. IOS Android. More>> ... .
Edit

U.S. External Analgesics Research Report 2024-2030: Hot/Cold Products, Kinesiology Tape, TENS Devices, and Infrared Therapy ...

Nasdaq Globe Newswire 06 Sep 2024
external analgesics market size is anticipated to reach USD 6.66 billion by 2030 and is projected to grow at the CAGR of 13.1% from 2024 to 2030 ... External Analgesics Market Report Highlights .
Edit

Analgesics Market Insights, Competitive Landscape and Market Forecast to 2030

Nasdaq Globe Newswire 15 Aug 2024
15, 2024 (GLOBE NEWSWIRE) -- The "Analgesics - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been ...
Edit

PainReform Announces Development and Successful Manufacturing of New Formulations Providing Anti-Inflammatory and Extended Analgesic Effects

Nasdaq Globe Newswire 12 Aug 2024
New formulations designed to enhance postoperative recovery. New formulations designed to enhance postoperative recovery ... .
Edit

Amending Over the Counter Monograph M013: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over the Counter Human Use (The eRulemaking Program)

Public Technologies 08 Aug 2024
Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Reopening the Comment Period ... Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use (OTC Monograph M013).
Edit

Charter Amendments, Establishments, Renewals and Terminations: Anesthetic and Analgesic Drug Products Advisory Committee (The eRulemaking Program)

Public Technologies 05 Aug 2024
Advisory Committee; Anesthetic and Analgesic Drug Products Advisory Committee; Renewal ... Members and the Chair are selected by the Commissioner or designee from among authorities knowledgeable in the fields of anesthesiology, analgesics (such as.
Edit

Adoption of Analgesic Drugs is Rising with Favorable Government Regulations, the Analgesics Market value to ...

Nasdaq Globe Newswire 31 Jul 2024
An In-depth Market Insights of Analgesics Market including Opioids, NSAIDs, Local Anesthetics, and Acetaminophen ...
Edit

Adolore BioTherapeutics Announces Publication of Compelling Preclinical Efficacy and Safety Data Supporting Adolore's Non-opioid Analgesic ...

Corsicana Daily Sun 30 Jul 2024
This publication validates Adolore's approach for the intracellular delivery of a non-opioid analgesic minigene to targeted sensory neurons via local administration ....
Edit

New Survey Shows Cannabis Could Reduce Prescription Analgesic Use

MENA FN 26 Jul 2024
(MENAFN - Investor Brand Network). The state of Ohio legalized the medical use of cannabis in 2016, making it the 25th state in the country to do so. As of March 2024, the state had registered ... .
Edit

Concentric Analgesics Announces Peer-Reviewed Publication of Positive Phase 2 Clinical Data in ANESTHESIOLOGY

Business Wire 24 Jul 2024
SAN FRANCISCO--(BUSINESS WIRE)--Concentric Analgesics, Inc., a clinical-stage biopharmaceutical ...
Edit

New analgesic could replace opioids over the long term

Science Daily 18 Jul 2024
They have been used as effective painkillers ... .
Edit

New analgesic could replace opioids over the long term (Johannes Gutenberg-Universität Mainz)

Public Technologies 17 Jul 2024
) Researchers at Mainz University have identified a natural active substance that may prove to be an effective alternative to opioids in the long run and could also help mitigate the opioid crisis ... There is thus an urgent need for safe analgesics.
Edit

Luye Pharma’s Analgesic Drug Mimeixin (Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-Release Tablets) Approved for ... (Luye Pharma Group Ltd)

Public Technologies 04 Jul 2024
In recent years, oxycodone in sustained-release tablets has become one of the most commonly used potent opioid analgesics for treating moderate to severe chronic cancer pain, playing a crucial role in clinical practice3.

Most Viewed

×